• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza Other Respir Viruses . The National Burden of Influenza-Associated Respiratory Illness Across Levels of Severity in Egypt, 2016-2019

tetano

Editor, Senior Moderator
Influenza Other Respir Viruses


. 2024 Dec;18(12):e70061.
doi: 10.1111/irv.70061. The National Burden of Influenza-Associated Respiratory Illness Across Levels of Severity in Egypt, 2016-2019

Manal Fahim[SUP] 1 [/SUP], Ola Deghedy[SUP] 1 [/SUP], Walaa Alim[SUP] 1 [/SUP], Reham Kamel[SUP] 1 [/SUP], Hossam Hassan[SUP] 2 [/SUP], Amira Mohsen[SUP] 2 [/SUP], Rania Attia[SUP] 3 [/SUP], Hala Abou El Naja[SUP] 3 [/SUP], Salma Afifi[SUP] 4 [/SUP], Stefano Tempia[SUP] 5 [/SUP], Amr Kandeel[SUP] 4 [/SUP]



Affiliations
Abstract

Introduction: Influenza burden (IB) estimates are crucial for monitoring disease trends, allocating limited resources, and promoting influenza vaccination. However, IB in Egypt is poorly understood. This study estimates the mean-seasonal IB in Egypt, across levels of severity by age and regions using sentinel surveillance data between 2016 and 2019.
Methods: Influenza surveillance was implemented among patients hospitalized with severe acute respiratory infection (SARI) at eight sentinel hospitals across Egypt. We estimated the influenza-associated SARI hospitalization in two governorates and then extrapolated nationally using the World Health Organization (WHO)-recommended methods. Thereafter, we estimated IB-associated mild/moderate illness and deaths using IB pyramid tool developed by WHO and the John Hopkins Center for Health Security. Rates were reported per 100,000 population.
Results: The estimated mean seasonal number of influenza-associated mild/moderate illness, hospitalized noncritically and critically ill patients, and deaths was 16,425,938 (95% CI: 1,150,888-40,409,614), 30,335 (95% CI: 9971-670,288), 9110 (95% CI: 580-16,321), and 2660 (95% CI: 154-9908), respectively. The highest rate of influenza-associated mild/moderate illness was among aged 5-14 year (22,932; 95% CI: 825-25,546.3), whereas the highest rates of severe influenza were among aged > 65 years (hospitalizations: 159.4, 95% CI: 121.7-205.0; deaths: 56.0, 95% CI: 0.6-111.0). Children aged < 5 years also experience high rates of influenza-associated hospitalization (52.0, 95% CI: 43.0-62.0).
Conclusions: The WHO method estimated a high burden of severe influenza among aged ≥ 65 and aged < 5 years in Egypt. To reduce severe IB, increased influenza vaccine uptake together with enhanced immunization strategies implementations among the elderly and children are warranted.

Keywords: burden; influenza virus; severe acute respiratory infection; surveillance.

 
Back
Top Bottom